# Open Label, 6-month Study for High Frequency and Chronic Migraine,

> **NCT06133491** · — · ACTIVE_NOT_RECRUITING · sponsor: **Ki Health Partners. LLC** · enrollment: 20 (estimated)

## Conditions studied

- Chronic Migraine, Headache

## Interventions

- **BIOLOGICAL:** Daxibotulinumtonix A

## Key facts

- **NCT ID:** NCT06133491
- **Lead sponsor:** Ki Health Partners. LLC
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-10-18
- **Primary completion:** 2024-09
- **Final completion:** 2024-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2024-08-27

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06133491

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06133491, "Open Label, 6-month Study for High Frequency and Chronic Migraine,". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06133491. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*